#3 - Trimble (NASDAQ:TRMB)
If you’re looking for a more technology-focused way to play the infrastructure segment, you may consider Trimble (NASDAQ:TRMB). Trimble is a hardware, software, and services company that competes in the Agriculture, Building & Construction, Geospatial, Transportation, and Natural Resource segments.
With a tagline of “Transforming the way the world works,” you’re starting with lofty expectations. Fortunately for investors, Trimble has delivered. TRMB stock has rewarded investors with a stock price appreciation of nearly 169% over the last five years. However, after hitting a point of resistance at approximately $45 per share in February, TRMB stock got trounced by the pandemic. But since that point, it’s come roaring back. And blew past that level of resistance and now sits at an all-time high.
On November 4, Trimble posted a strong earnings report in which the company beat analysts’ estimates on both the top and bottom lines. Despite that, analysts’ have a consensus price target that suggests the stock could travel lower. However, with more stimulus, a near certainty would appear to be a buy on the dip opportunity.
About Trimble
Trimble Inc provides technology solutions that enable professionals and field mobile workers to enhance or transform their work processes worldwide. The company's Buildings and Infrastructure segment offers field and office software for project design and visualization; systems to guide and control construction equipment; software for 3D design and data sharing; systems to monitor, track, and manage assets, equipment, and workers; software to share and communicate data; program management solutions for construction owners; 3D conceptual design and modeling software; building information modeling software; enterprise resource planning, project management, and project collaboration solutions; integrated site layout and measurement systems; cost estimating, scheduling, and project controls solutions; and applications for sub-contractors and trades.
Read More - Current Price
- $75.28
- Consensus Rating
- Buy
- Ratings Breakdown
- 5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $79.00 (4.9% Upside)
